Package 50268-681-15

{"route": ["ORAL"], "spl_id": "2b4c161c-f20b-38d5-e063-6394a90a8a79", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["fd8da0e9-d69b-7587-e053-6294a90a33c0"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOX (50268-681-15)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-681-11)", "package_ndc": "50268-681-15", "marketing_start_date": "20230607"}], "brand_name": "Oxcarbazepine", "product_id": "50268-681_2b4c161c-f20b-38d5-e063-6394a90a8a79", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50268-681", "generic_name": "Oxcarbazepine", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "600 mg/1"}], "application_number": "ANDA215939", "marketing_category": "ANDA", "marketing_start_date": "20230607", "listing_expiration_date": "20261231"}